Overproduction of Clavulanic Acid by UV Mutagenesis of Streptomyces clavuligerus

authors:

avatar Hassan Korbekandi a , avatar Parisa Darkhal b , avatar Zohreh Hojati c , avatar Daryoush Abedi b , avatar Javad Hamedi d , avatar Meraj Pourhosein a

Genetics and Molecular Biology Department, Isfahan University of Medical Sciences, Isfahan, Iran.
Pharmaceutical Biotechnology Department, Isfahan University of Medical Sciences, Isfahan, Iran.
Genetics Department, Isfahan University, Isfahan, Iran.
Biology Department, Tehran University, Tehran, Iran.
Warning: No corresponding author defined!
Iranian Journal of Pharmaceutical Research : IJPR: Vol.9, issue 2; 177-181
article type: Original Article
received: December , 2009
accepted: February , 2010
DOI: https://doi.org/10.22037/ijpr.2010.854

how to cite: Korbekandi H, Darkhal P, Hojati Z, Abedi D, Hamedi J, et al. Overproduction of Clavulanic Acid by UV Mutagenesis of Streptomyces clavuligerus. Iran J Pharm Res. 2010;9(2):e126057. https://doi.org/10.22037/ijpr.2010.854.

Abstract

Clavulanic acid is produced industrially by fermentation of Streptomyces clavuligerus and researches have increased its production by strain improvement, recombinant DNA technology, and media composition and growth condition optimization. The main objective of this study was to increase the level of clavulanic acid production from Streptomyces clavuligerus (DSM 738), using UV irradiation. After incubation, the spores and aerial mycelia were scraped off the agar plate by a sterile loop. After passing through a cotton wool, the serially diluted spore suspension was spread on GYM- agar containing caffeine. The plates were irradiated with UV light, wrapped in aluminum foil and incubated. The colonies were sub-cultured again to express the mutations. An aliquot of the spore suspension prepared from the resulted culture was poured in GYM agar plates and incubated. The plates were overlaid with nutrient-agar containing penicillin G and Klebsiela pneumoniae, and incubated. The inhibition zone diameter was measured and compared with the wild type colony. Repeating this procedure, the overproducer mutants were selected. Concentration of clavulanic acid was determined by HPLC analysis. It was concluded that secondary metabolites, mainly antibiotics containing clavulanic acid, were produced about 6–7 days after the growth, and concentration of clavulanic acid was increased up to two-folds after UV mutagenesis.

Introduction

Streptomyces clavuligerus is an actinomycet, which produces more than 21 bioactive secondary metabolites (1-3). Between them, metabolites with β-lactam ring such as cephamycyn C, penicillin N and cephalosponins with antibacterial effect, and clavulanic acid, a β-lactamase inhibitor, are more important (4). Clavulanic acid is a β-lactam antibiotic with weak antibacterial effect and strong β-lactamase inhibition (4-6). Augmentin®, a brand name, containing a combination of amoxicillin and potassium clavulanate, is one of the best selling antibiotics (7-15). Clavulanic acid is produced industrially by fermentation of Streptomyces clavuligerus and researches have increased its concentration (up to ≈1.4 g L-1) by strain improvement, recombinant DNA technology, and media composition and growth conditions optimization (3, 7, 10, 15-24). UV irradiation is one of the strain improvement strategies through random mutation (7, 16). UV radiation, in the range of 200-300 nm, produces thymidine dimmers and increases probability of deletion during the duplication process (25, 26). UV is a very convenient and relatively safe mutagen (27), however very few researchers (7, 16) have used this technique to overproduce clavulanic acid. The main objective of this study was to increase the level of clavulanic acid production by S. clavuligerus, using UV irradiation.

Experimental

Microorganism and cultivation

Streptomyces clavuligerus (DSM 738) was revitalized on GYM- broth and maintained on GYM-Agar. Sodium chloride solution (0.9%) containing tween-80 (0.2%) was poured onto GYM-Agar medium, on which S. clavuligerus was grown for 7 days at 28 °C. The spores and aerial mycelia were scraped off the agar surface, using a sterile loop. After filtering through cotton wool, the spore suspension was serially diluted to 102 CFU mL-1 and one mL of this suspension was poured and spread onto each sterile glass plate containing GYM-Agar and caffeine (0.5 g L-1) (28).

UV Irradiation

The plates were irradiated with UV light (200-300 nm, 1.7 W m-2) for 20 min, at a distance of 8 cm. After the irradiation, in order to protect against photoreactivation, the plates were wrapped with aluminum foil and incubated for 7 days. Finally, the colonies were sub-cultured (7 days, 28 °C) again to express and stabilize the mutants.

Bioassay

A radically modified bioassay method, based on the method developed by Lee et al (7), was used. Tenμµl of the spore suspension (102 CFU mL-1), prepared from the resulted culture, was poured into each of the 3 wells (out of 4 wells) in GYM- agar plates. A spore suspension (102 CFU mL-1) of the wild type micro-organism was poured into the 4th well. After an incubation period of 6 days at 28 °C, the plates were overlaid with nutrient-agar containing penicillin G (7 µg mL-1) and Klebsiela pneumoniae (105 CFU mL-1), and at the end again incubated for 24 h at 37 °C. The inhibition zone diameter was measured and compared with the wild type colony.

Clavulanic acid production

The pH of the seed medium (20 mL) consisting of peptone (1%), malt (1%) and glycerol (2%) was adjusted to 7.0 ± 0.1. The medium was inoculated (5%) and incubated (28 °C, 24 h, 220 rpm) in a 100 mL shaking flask. The production medium (50 mL) containing malt extract (3%), glycerol (0.5%), soy flour (0.5%), FeSO4 (0.0001%), and MnSO4 (0.0001%) was inoculated (5%) with the seed culture and incubated (28 °C, 220 rpm) in a 250 mL shaking flask.

HPLC analysis

Clavulanic acid was quantified by HPLC, using a reversed-phase column (C-18). The mobile phase contained KH2PO4 (50 mM, 70%, 0.348 mL min-1) and methanol (30%, 0.157 mL min-1) and the pH was adjusted to 3.2. Samples were derivatized using imidazole. The derivatives were detected at 311 nm (29).

Statistical analysis

Statistical analyses were performed through the Mann-Whitney non-parametric test, using the statistical package SPSS for Windows version 13.0 software (SPSS Inc, Illinois).

Results

During the subculturing of S. clavuligerus on GYM agar for sporulation, it was observed that by using deep (≈ 8 mm) agar plates denser colonies appeared with more grey pigments. Pale yellow droplets were secreted 6-7 days after the growth, which disappeared after leaving holes on the surface of S. clavuligerus colonies for a period of 24 h. This procedure has not been described before.

It seems that a thicker layer of agar in the plates, resulting in a greater population of the microorganism, could cause a higher and faster production of secondary metabolites, possibly containing antibiotics and clavulanic acid. After a while, these droplets might have been diffused in the plates.

Development of a bioassay for clavulanic acid

In order to screen overproducing mutants, a cheap, quick and fairly reliable bioassay method considering S. clavuligerus as clavulanic acid producer, and K. pneumonia as the sensitive microorganism was needed. When the bioassay was performed about 4 days after the growth of S. clavuligerus, not only the inhibition zone of K. pneumonia was not observed, but also a significant overgrowth zone was seen. However, when this assay was performed after 6 days, the inhibition zone was clearly observed (Figure 1).

The developed bioassay plates used in this study

The developed bioassay plates used in this study

Figure 1

It might be interpreted that some primary metabolites stimulating the growth are secreted by S. clavuligerus colonies during 4 days, which can lead to a faster growth of K. pneumonia. On the other hand, after 6 days, secondary metabolites (such as clavulanic acid), inhibiting the growth, might have been produced.

Screening of overproducing mutants

As mentioned earlier, a bioassay method was used to screen the overproducer mutants. Fourteen (out of 105) mutants showed inhibition zones more than the wild type control, with higher values for the mutants M60, M23 and M61 (Figure 2). Based on the Mann-Whitney statistical test, the differences between groups were found to be significant (P < 0.001).

The ratio of mutants inhibition zone diameter over the wild type inhibition zone diameter in selected mutants- Data points have been expressed as mean ± standard error (n = 3).

The ratio of mutants inhibition zone diameter over the wild type inhibition zone diameter in selected mutants- Data points have been expressed as mean ± standard error (n = 3).

Figure 2

Clavulanic acid determination by HPLC

The bioassay method used did not prove the production of clavulanic acid by the screened mutants. Therefore, we needed to confirm this and determine clavulanic acid concentration. Overproduction of clavulanic acid by the screened mutants was verified by the HPLC measurements (Figures 3 and 4). Intra-day and inter-day variations in precision (CV %) and accuracy (Error %) were found to be acceptable.

Chromatogram of the products, obtained using a reversed-phase column (C-18). The mobile phase contained KH2PO4 (50 mM, 70%, 0.348 mL min-1) and methanol (30%, 0.157 mL min-1) and the pH was adjusted to 3.2. Samples were derivatized using imidazole, and they were detected at 311 nm

Chromatogram of the products, obtained using a reversed-phase column (C-18). The mobile phase contained KH2PO4 (50 mM, 70%, 0.348 mL min-1) and methanol (30%, 0.157 mL min-1) and the pH was adjusted to 3.2. Samples were derivatized using imidazole, and they were detected at 311 nm

Figure 3

Clavulanic acid versus biomass production. Clavulanic acid concentrations (white columns) were measured by HPLC, and the wet biomass (gray columns) was measured by weighing. Data points have been expressed as mean ± standard error (n = 3).

Clavulanic acid versus biomass production. Clavulanic acid concentrations (white columns) were measured by HPLC, and the wet biomass (gray columns) was measured by weighing. Data points have been expressed as mean ± standard error (n = 3).

Figure 4

Comparing the concentrations of produced clavulanic acid with the biomasses of related mutants, clavulanic acid concentrations were found to be different among the various mutants. However, there was no considerable difference in the biomass concentrations (Figure 4). It might be interpreted that the overproduction of clavulanic acid, following the mutations, is not the result of overgrowth. This could be due to the changes in the metabolic pathway of the microorganism, resulting in the overproduction of clavulanic acid There was an analogy between the bioassay and HPLC method (Fig. 5), except in few cases, which might be due to the overproduction of other growth limiting factors.

Clavulanic acid production versus the ratio of mutant zone diameter to control zone diameter. Clavulanic acid concentrations (white columns) were measured by HPLC, and the ratio of mutant zone diameter to control zone diameter (gray columns) was measured by Vernier caliper and division. Data points have been expressed as mean ± standard error (n = 3).

Clavulanic acid production versus the ratio of mutant zone diameter to control zone diameter. Clavulanic acid concentrations (white columns) were measured by HPLC, and the ratio of mutant zone diameter to control zone diameter (gray columns) was measured by Vernier caliper and division. Data points have been expressed as mean ± standard error (n = 3).

Figure 5

Productivity of the selected mutants was also calculated (Table 1).

Table 1

Productivity of four selected mutants, investigated in this study

Mutant numberClavulanic acid concentration(mg L-1)Production time(h)Productivity(mg L-1h-1)
M2293.11724.07
M6242.67723.37
M60343.87724.77
M61244.38723.39

Discussion

The production of clavulanic acid was successfully increased 1.8 times by UV mutagenesis. It seems that the mutations occurred in the genes which were involved in the metabolic pathway of clavulanic acid production, but not in the primary metabolites responsible for growth. These mutants can be used industrially for production of clavulanic acid. A group of researches (7) increased clavulanic acid production up to 8 folds by UV mutagenesis and medium optimization. We increased it up to 1.8 folds, using random mutagenesis, which can be continued more considering the fact that “mutation is an accidental event”. In another study (30), we also inserted claR gene in E. coli XLI blue, using PZSclaR plasmid, as a vector to increase clavulanic acid production. In the near future we will combine these methods, and by using the medium optimization, it is hoped to increase the productivity.

Acknowledgements

References

  • 1.

    Muth G, Brolle DF, Wohlleben W. Genetics of Streptomyces. In: Demain AL, Davais J, editors. Manual of Industrial Microbiology and Bacteriology. Washington DC: ASM Press; 1998. p. 353-67.

  • 2.

    Williams ST, Goodfellow M, Alderson G. Genus Streptomyces. In: Williams ST, Sharpe ME, Holt JG, editors. Bergey’s Manual of Systematic Bacteriology. 4th ed. New York: Springer; 1998. 92 p.

  • 3.

    Gouveia ER, Baptista-Neto A, Badino AC, Hokka CO. Optimization of medium composition for clavulanic acid production by Streptomyces clavuligerus. Bacteriol. Lett. 2001;23:157-61.

  • 4.

    Liras P, Rodryiguez-Garcyia A. Clavulanic acid, a beta lactamase inhibitor: biosynthesis and molecular genetics. Appl. Microbiol. Biotechnol. 2000;54:467-75. [PubMed ID: 11092620].

  • 5.

    Tahlan K, Anders C, Jensen SE. The paralogous pairs of genes involved in clavulanic acid and clavam metabolite biosynthesis are differently regulated in Streptomyces clavuligerus. J. Bacteriol. 2004;186:6286-97. [PubMed ID: 15342599].

  • 6.

    Elson SW, Baggaley KH, Davison M, Fuolston M, Nicholson NH, Risbridger GD. The identification of three new biosynthetic intermediates and one further biosynthetic enzyme in the clavulanic acid pathway. J. Chem. Soc. Chem. Commun. 1993:1212-14.

  • 7.

    Lee SD, Park SW, Oh KK, Hong SI, Kim SW. Improvement for the production of clavulanic acid by mutant Streptomyces clavuligerus. Lett. Appl. Microbiol. 2002;34:370-5. [PubMed ID: 11967061].

  • 8.

    Rolinson G. A review of the microbiology of amoxicillin/clavulanic acid over the 15 year period 1978-1993. J. Chemother. 1994;6:283-318. [PubMed ID: 7861195].

  • 9.

    Richmond MH, Sykes R. The beta lactamase of gram negative bacteria and their possible physiological role. Adv. Microb. Physiol. 1973;9:31-88. [PubMed ID: 4581138].

  • 10.

    Lynch HC, Yang Y. Degradation products of clavulanic acid promote clavulanic acid production in cultures of Streptomyces clavuligerus. Enzyme. Microbial. Tech. 2004;34:48-54.

  • 11.

    Leflon-Guibout V, Speldooren V, Heym B, Nicholas-Chanoine M. Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla (TEM) genes. Antimicrob. Agents Chemother. 2000;44:2709-14. [PubMed ID: 10991849].

  • 12.

    Janicka G, Wojciechowska D, Harenska K, Porada J, Klyszejko C. The resistance to beta lactam antibiotics of lactose-positive and lactose-negative strains of Escherichia coli. Acta Microbiaol. Pol. 1997;46:399-403.

  • 13.

    Natsch S, Conrad C, Hartmeier C, Schmid B. Use of amoxicillin-clavulanate resistance in Escherichia coli over a 4-year period. Infect. Control. Hosp. Epidemiol. 1998;19:653-6. [PubMed ID: 9778163].

  • 14.

    Vanhoof R, Carpentier M, Delannoy P, Fagnart O, Lontie M, Mans I. Study of the in vitro activity of amoxicillin-clavulanic acid and other beta-lactam antibiotics against Escherichia coli isolated urine specimens. Acta Clin. Belg. 2001;56:32-7. [PubMed ID: 11307481].

  • 15.

    Rosa JC, Baptista-Neto A, Hokka CO, Badino AC. Influence of dissolved oxygen and shear conditions on clavulanic acid production by Streptomyces clavuligerus. Bioprocess. Biosyst. Eng. 2005;27:99-104. [PubMed ID: 15592878].

  • 16.

    Hodgson JE, Fosberry AP, Rawlinson NS, Ross HN, Neal RJ, Arnell JC, Earl AJ, Lawlor EJ. Clavulanic acid biosynthesis in Streptomyces clavuligerus: gene cloning and characterization. Gene. 1995;166:49-55. [PubMed ID: 8529893].

  • 17.

    Cochet N, Demain AL. Effect of water activity on production of beta-lactam antibiotics by Streptomyces clavuligerus in submerged culture. J. Appl. Bacteriol. 1996;80:333-7. [PubMed ID: 8852680].

  • 18.

    Sircar A, Sridhar P, Das PK. Optimization of solid state medium for the production of clavulanic acid by Streptomyces clavuligerus. Process Biochem. 1998;33:283-9.

  • 19.

    Kwon HJ, Kim SU. Enhanced biosynthesis of clavulanic acid in Streptomyces clavuligerus due to oxidative challenge by redox-cycling agents. Appl. Microbiol. Biotechnol. 1998;49:77-83. [PubMed ID: 9487713].

  • 20.

    Large KP, Ison AP, Williams DJ. The effect of agitation rate on lipid utilization and clavulanic acid production in Streptomyces clavuligerus. J. Biotechnol. 1998;63:111-19.

  • 21.

    Chen KC, Lin YH, Wu JY, Hwang SCJ. Enhancement of clavulanic acid production in Streptomyces clavuligerus with ornithine feeding. Enzyme. Microbial. Tech. 2003;32:152-6.

  • 22.

    Wang YH, Yang B, Ren J, Dong ML, Liang D, Xu AL. Optimization of medium composition for the production of clavulanic acid by Streptomyces clavuligerus. Process Biochem. 2005;40:1161-6.

  • 23.

    Ortiz SCA, Hokka CO, Badino AC. Utilization of soybean derivatives on clavulanic acid production by Streptomyces clavuligerus. Enzyme Microbial. Tech. 2007;40:1071-77.

  • 24.

    Bushell ME, Kirk S, Zhao HJ, Avignone-Rossa CA. Manipulation of the physiology of clavulanic acid biosynthesis with the aid of metabolic flux analysis. Enzyme Microbial. Tech. 2006;39:149-57.

  • 25.

    Aneja KR. Experiments in Microbiology, Plant Pathology and Biotechnology. 4th ed. New Delhi: New Age International publications; 2003. p. 131-136.

  • 26.

    Schaaper RM, Dunn RL. Spectra of spontaneous mutations in Escherichia coli strains defective in mismatch correction: the nature of in vivo DNA replication errors, Proc. Acad. Sci. 1987;84:6220-24.

  • 27.

    Kieser T, Bibb MJ, Butner MJ, Chatter KF, Hopwood DA. Practical Streptomyces Genetics. UK: The John Innes Foundation; 2000. p. 99-106.

  • 28.

    Henrissat B, Driguez H, Veit C, Schulein W. Synergism of celluloses from Trichoderma reesei in the degradation of cellulose. Biotechnol. 1985;3:722-6.

  • 29.

    Foulstone M, Reading C. Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography. Antimicrob. Agents Chemother. 1982;22:753-62. [PubMed ID: 7181486].

  • 30.

    Salehi Z. Detection and Isolation of claR regulatory gene from Streptomyces clavuligerus [dissertation]. Isfahan: Isfahan University; 2006. 109 p.